Hibert; Marcel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hibert; Marcel.The latest application filed is for "pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines".

Company Profile

1.10.13

Hibert; Marcel - Eschau FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines Grant 11,046,657 - Bonnet , et al. June 29, 2	2021-06-29
Pyrimidinone Derivatives and Uses Thereof to Neutralize the Biological Activity of Chemokines App 20200181093 - Bonnet; Dominique ; et al.	2020-06-11
Pyridazine compounds, compositions and methods Grant 9,663,493 - Watterson , et al. May 30, 2	2017-05-30
Pyridazine compounds, compositions and methods Grant 9,527,819 - Watterson , et al. December 27, 2	2016-12-27
Pyridazine Compounds, Compositions And Methods App 20160326139 - WATTERSON; D. Martin ; et al.	2016-11-10
Pyridazine Compounds, Compositions And Methods App 20150175555 - WATTERSON; D. Martin ; et al.	2015-06-25
Pyridazine compounds, compositions and methods Grant 8,933,076 - Watterson , et al. January 13, 2	2015-01-13
Bisacodyl And Its Analogues As Drugs For Use In The Treatment Of Cancer App 20140186872 - Feve; Marie ; et al.	2014-07-03
Pyridazine compounds, compositions and methods Grant 8,367,672 - Watterson , et al. February 5, 2	2013-02-05
Pyridazine Compounds, Compositions And Methods App 20120245125 - Watterson; D. Martin ; et al.	2012-09-27
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death Grant 8,088,774 - Watterson , et al. January 3, 2	2012-01-03
Pyridazine compounds and methods Grant 8,063,047 - Watterson , et al. November 22, 2	2011-11-22
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death Grant 7,888,357 - Watterson , et al. February 15, 2	2011-02-15
Anti-Inflammatory And Protein Kinase Inhibitor Compositions And Related Methods For Downregulation Of Detrimental Cellular Responses And Inhibition Of Cell Death App 20100317665 - Watterson; D.M. ; et al.	2010-12-16
Novel Compounds Which Interact With PEA-15 App 20090170749 - Hibert; Marcel ; et al.	2009-07-02
Pyridazine Compounds And Methods App 20090029985 - Watterson; Martin ; et al.	2009-01-29
Pyridazine Compounds, Compositions and Methods App 20080318899 - Watterson; Martin ; et al.	2008-12-25
Method for isolating an allosteric effector of a receptor App 20060194259 - Galzi; Jean-Luc ; et al.	2006-08-31
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death App 20060073472 - Watterson; D. M. ; et al.	2006-04-06
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death App 20030176437 - Watterson, D.M. ; et al.	2003-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.